×
News Home

Where Does Zogenix, Inc. (ZGNX) Stock Fall in the Biotechnology Field After It Is Down -4.57% This Week?

Friday, January 14, 2022 02:52 PM | InvestorsObserver Analysts
Where Does Zogenix, Inc. (ZGNX) Stock Fall in the Biotechnology Field After It Is Down -4.57% This Week?

Zogenix, Inc. (ZGNX) is near the top in its industry group according to InvestorsObserver. ZGNX gets an overall rating of 51. That means it scores higher than 51 percent of stocks. Zogenix, Inc. gets a 83 rank in the Biotechnology industry. Biotechnology is number 101 out of 148 industries.

Overall Score - 51
ZGNX has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on ZGNX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Zogenix, Inc. Stock Today?

Zogenix, Inc. (ZGNX) stock has gained 1.62% while the S&P 500 has fallen -0.33% as of 2:44 PM on Friday, Jan 14. ZGNX has risen $0.25 from the previous closing price of $15.40 on volume of 222,727 shares. Over the past year the S&P 500 has gained 22.34% while ZGNX has fallen -17.50%. ZGNX lost -$4.35 per share the over the last 12 months. Click Here to get the full Stock Report for Zogenix, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App